KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) EPS (Basic) (2016 - 2025)

Biogen (BIIB) has 17 years of EPS (Basic) data on record, last reported at -$0.33 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 118.03% year-over-year to -$0.33; the TTM value through Dec 2025 reached $8.83, down 21.23%, while the annual FY2025 figure was $8.83, 21.23% down from the prior year.
  • EPS (Basic) reached -$0.33 in Q4 2025 per BIIB's latest filing, down from $3.18 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $7.86 in Q3 2022 and bottomed at -$0.48 in Q3 2023.
  • Average EPS (Basic) over 5 years is $2.98, with a median of $2.7 recorded in 2021.
  • Peak YoY movement for EPS (Basic): soared 654.17% in 2024, then plummeted 118.03% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $2.51 in 2021, then soared by 52.99% to $3.84 in 2022, then plummeted by 55.21% to $1.72 in 2023, then increased by 6.4% to $1.83 in 2024, then tumbled by 118.03% to -$0.33 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.33 in Q4 2025, $3.18 in Q3 2025, and $4.33 in Q2 2025.